MEETING OBJECTIVES

Do not miss an exciting opportunity to join the renowned internal medicine experts, Dr Luis Ostrosky-Zeichner (USA) and Dr Rafael Franco (Mexico). With the meeting Chaired by Dr Fernando Antonio Silva, Pfizer Mexico, this session will provide regional and international perspectives on the management of COVID-19. Dr Franco will shine a spotlight on how and why we can continue to optimise COVID-19 outcomes in high-risk patients. Dr Ostrosky-Zeichner will then discuss the various options available for the treatment of COVID-19. Finally, both specialists will review a series of case studies, an opportunity to immerse yourself in the learnings and discuss practical implementation in your region.

This webinar aims to:

• Emphasise that COVID-19 is still an ongoing issue globally, with new variants of concern arising, and many patient groups still at high risk of hospitalisation

• Re-enforce the role of internal medicine in optimising patient outcomes, highlighting which patients are at high risk of progressing to severe COVID-19, focusing on those with chronic illness

• Highlight the importance of early and appropriate treatment in these patient groups (to avoid hospitalisation and complications)

• Review how the focus of the medical community is changing as the treatment landscape for COVID-19 continues to evolve

SPEAKERS

Dr Fernando Antonio Silva

Pfizer Hospital Business Unit
Medical Lead, Mexico

Dr Luis Ostrosky-Zeichner

Chief of the Infectious Diseases Division
and Vice Chair of Medicine for Healthcare
Quality, University of Texas Health
Science Center, Texas, USA

SEE BIO

Dr Rafael Franco

Head of the Division of Infectious
Diseases of the National Institute
of Rehabilitation Luis Guillermo Ibarra,
Mexico City, Mexico

SEE BIO